Sebok Kumar Halder, PhD - Publications

Affiliations: 
 

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Halder SK, Milner R. Exaggerated hypoxic vascular breakdown in aged brain due to reduced microglial vasculo-protection. Aging Cell. e13720. PMID 36130175 DOI: 10.1111/acel.13720  0.427
2022 Halder SK, Sapkota A, Milner R. The impact of genetic manipulation of laminin and integrins at the blood-brain barrier. Fluids and Barriers of the Cns. 19: 50. PMID 35690759 DOI: 10.1186/s12987-022-00346-8  0.379
2021 Halder SK, Milner R. The impact of chronic mild hypoxia on cerebrovascular remodelling; uncoupling of angiogenesis and vascular breakdown. Fluids and Barriers of the Cns. 18: 50. PMID 34789271 DOI: 10.1186/s12987-021-00284-x  0.366
2021 Matsunaga H, Halder SK, Ueda H. Annexin A2 Flop-Out Mediates the Non-Vesicular Release of DAMPs/Alarmins from C6 Glioma Cells Induced by Serum-Free Conditions. Cells. 10. PMID 33807671 DOI: 10.3390/cells10030567  0.301
2021 Halder SK, Milner R. The GFAP Monoclonal Antibody GA-5 Identifies Astrocyte Remodeling and Glio-Vascular Uncoupling During the Evolution of EAE. Cellular and Molecular Neurobiology. PMID 33544272 DOI: 10.1007/s10571-021-01049-8  0.304
2020 Halder SK, Milner R. Hypoxia in multiple sclerosis; is it the chicken or the egg? Brain : a Journal of Neurology. PMID 33351069 DOI: 10.1093/brain/awaa427  0.306
2020 Halder SK, Milner R. Mild hypoxia triggers transient blood-brain barrier disruption: a fundamental protective role for microglia. Acta Neuropathologica Communications. 8: 175. PMID 33115539 DOI: 10.1186/s40478-020-01051-z  0.463
2020 Matsunaga H, Halder SK, Ueda H. Involvement of SNARE Protein Interaction for Non-classical Release of DAMPs/Alarmins Proteins, Prothymosin Alpha and S100A13. Cellular and Molecular Neurobiology. PMID 32856232 DOI: 10.1007/s10571-020-00950-y  0.315
2020 Halder SK, Milner R. Chronic mild hypoxia accelerates recovery from preexisting EAE by enhancing vascular integrity and apoptosis of infiltrated monocytes. Proceedings of the National Academy of Sciences of the United States of America. 117: 11126-11135. PMID 32371484 DOI: 10.1073/pnas.1920935117  0.416
2020 Kant R, Halder SK, Fernández JA, Griffin JH, Milner R. Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation. Frontiers in Neuroscience. 14: 333. PMID 32351356 DOI: 10.3389/Fnins.2020.00333  0.365
2020 Halder SK, Matsunaga H, Ueda H. Experimental evidence for the involvement of F/F ATPase and subsequent P2Y receptor activation in prothymosin alpha-induced protection of retinal ischemic damage. Journal of Pharmacological Sciences. PMID 32156464 DOI: 10.1016/j.jphs.2020.01.008  0.324
2020 Sasaki K, Halder SK, Matsunaga H, Ueda H. Beneficial actions of prothymosin alpha-mimetic hexapeptide on central post-stroke pain, reduced social activity, learning-deficit and depression following cerebral ischemia in mice. Peptides. 126: 170265. PMID 31982448 DOI: 10.1016/j.peptides.2020.170265  0.367
2019 Halder SK, Milner R. A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord. Proceedings of the National Academy of Sciences of the United States of America. PMID 31772011 DOI: 10.1073/pnas.1912178116  0.388
2019 Halder SK, Sasaki K, Ueda H. Gγ7-specific prothymosin alpha deletion causes stress- and age-dependent motor dysfunction and anxiety. Biochemical and Biophysical Research Communications. PMID 31759625 DOI: 10.1016/j.bbrc.2019.11.103  0.358
2019 Halder SK, Matsunaga H, Ueda H. Prothymosin alpha and its mimetic hexapeptide improve delayed tPA-induced brain damage following cerebral ischemia. Journal of Neurochemistry. PMID 31454420 DOI: 10.1111/jnc.14858  0.4
2019 Kant R, Halder SK, Bix GJ, Milner R. Absence of endothelial α5β1 integrin triggers early onset of experimental autoimmune encephalomyelitis due to reduced vascular remodeling and compromised vascular integrity. Acta Neuropathologica Communications. 7: 11. PMID 30678721 DOI: 10.1186/S40478-019-0659-9  0.412
2018 Halder SK, Kant R, Milner R. Hypoxic pre-conditioning suppresses experimental autoimmune encephalomyelitis by modifying multiple properties of blood vessels. Acta Neuropathologica Communications. 6: 86. PMID 30176931 DOI: 10.1186/s40478-018-0590-5  0.434
2018 Halder SK, Ueda H. Amlexanox inhibits cerebral ischemia-induced delayed astrocytic high-mobility group box 1 release and subsequent brain damage. The Journal of Pharmacology and Experimental Therapeutics. PMID 29330155 DOI: 10.1124/jpet.117.245340  0.396
2018 Halder SK, Kant R, Milner R. Chronic mild hypoxia promotes profound vascular remodeling in spinal cord blood vessels, preferentially in white matter, via an α5β1 integrin-mediated mechanism. Angiogenesis. PMID 29299782 DOI: 10.1007/s10456-017-9593-2  0.375
2017 Welser JV, Halder SK, Kant R, Boroujerdi A, Milner R. Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression. Journal of Neuroinflammation. 14: 217. PMID 29121970 DOI: 10.1186/s12974-017-0987-2  0.445
2017 Ueda H, Sasaki K, Halder SK, Deguchi Y, Takao K, Miyakawa T, Tajima A. Prothymosin alpha-deficiency enhances anxiety-like behaviors and impairs learning/memory-functions and neurogenesis. Journal of Neurochemistry. PMID 28122138 DOI: 10.1111/jnc.13963  0.358
2016 Arsenault J, Gholizadeh S, Niibori Y, Pacey LK, Halder SK, Koxhioni E, Konno A, Hirai H, Hampson DR. FMRP Expression Levels in Mouse CNS Neurons Determine Behavioral Phenotype. Human Gene Therapy. PMID 27604541 DOI: 10.1089/Hum.2016.090  0.337
2016 Maeda S, Sasaki K, Halder SK, Fujita W, Ueda H. Neuroprotective DAMPs member prothymosin alpha has additional beneficial actions against cerebral ischemia-induced vascular damages. Journal of Pharmacological Sciences. PMID 27543170 DOI: 10.1016/j.jphs.2016.05.006  0.448
2016 Ueda H, Halder SK, Matsunaga H, Sasaki K, Maeda S. Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia-reperfusion. Neuroscience. PMID 26779836 DOI: 10.1016/j.neuroscience.2016.01.007  0.35
2015 Halder SK, Matsunaga H, Ishii KJ, Ueda H. Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina. Journal of Neurochemistry. 135: 1161-77. PMID 26364961 DOI: 10.1111/jnc.13356  0.374
2015 Gholizadeh S, Halder SK, Hampson DR. Expression of fragile X mental retardation protein in neurons and glia of the developing and adult mouse brain. Brain Research. 1596: 22-30. PMID 25446451 DOI: 10.1016/j.brainres.2014.11.023  0.348
2015 Arsenault J, Gholizadeh S, Koxhioni E, Halder SK, Hampson DR. 17. Gene Therapy Strategies to Treat Fragile X Syndrome Molecular Therapy. 23: S7-S8. DOI: 10.1016/S1525-0016(16)33621-8  0.185
2013 Halder SK, Matsunaga H, Ishii KJ, Akira S, Miyake K, Ueda H. Retinal cell type-specific prevention of ischemia-induced damages by LPS-TLR4 signaling through microglia. Journal of Neurochemistry. 126: 243-60. PMID 23574143 DOI: 10.1111/jnc.12262  0.341
2013 Halder SK, Sugimoto J, Matsunaga H, Ueda H. Therapeutic benefits of 9-amino acid peptide derived from prothymosin alpha against ischemic damages. Peptides. 43: 68-75. PMID 23499560 DOI: 10.1016/j.peptides.2013.02.022  0.38
2013 Halder SK, Yano R, Chun J, Ueda H. Involvement of LPA1 receptor signaling in cerebral ischemia-induced neuropathic pain. Neuroscience. 235: 10-5. PMID 23318243 DOI: 10.1016/j.neuroscience.2013.01.005  0.269
2013 Halder SK, Matsunaga H, Yamaguchi H, Ueda H. Novel neuroprotective action of prothymosin α-derived peptide against retinal and brain ischemic damages. Journal of Neurochemistry. 125: 713-23. PMID 23278181 DOI: 10.1111/jnc.12132  0.435
2012 Ueda H, Matsunaga H, Halder SK. Prothymosin α plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms. Annals of the New York Academy of Sciences. 1269: 34-43. PMID 23045968 DOI: 10.1111/j.1749-6632.2012.06675.x  0.331
2012 Halder SK, Matsunaga H, Ueda H. Neuron-specific non-classical release of prothymosin alpha: a novel neuroprotective damage-associated molecular patterns. Journal of Neurochemistry. 123: 262-75. PMID 22853710 DOI: 10.1111/j.1471-4159.2012.07897.x  0.382
2012 Halder SK, Ueda H. Regional distribution and cell type-specific subcellular localization of Prothymosin alpha in brain. Cellular and Molecular Neurobiology. 32: 59-66. PMID 21750924 DOI: 10.1007/s10571-011-9734-x  0.348
Show low-probability matches.